{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:48Z","timestamp":1792189188186,"version":"4.4.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008523","name":"Center for Clinical and Translational Science","doi-asserted-by":"publisher","award":["UL1TR002377"],"award-info":[{"award-number":["UL1TR002377"]}],"id":[{"id":"10.13039\/100008523","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pneumocystis jirovecii pneumonia (PCP) is increasingly seen in patients who are non-HIV immunocompromised hosts, yet modern risk factors and outcomes are poorly recognized and defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review was conducted of adult patients who met criteria for proven or probable PCP from 2017 to 2024 across a large academic multicenter health system. The primary outcome was mortality among cohorts, defined by etiology of immunosuppression through univariate and age-adjusted logistic regression. Secondary analyses included trends in annual diagnoses and testing patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 701 patients met criteria for inclusion, representing one of the largest clinically characterized cohorts of PCP to date. The median age was 65 years (IQR, 54\u201373) and 62% were male. The most common risk groups were hematologic malignancy (32.2%), solid tumor cancers receiving chemotherapy (22.4%), and autoimmune disease with immunosuppression (17.7%). Annual PCP diagnoses increased at a rate of 15.8% (95% CI, 8.9%\u201323.2%) in parallel with increased testing. Only 5.4% of patients were receiving prophylaxis at the time of diagnosis. Overall mortality was 20% (95% CI, 17%\u201323%) and highest in cirrhosis (adjusted odds ratio, 6.24; 95% CI, 2.84\u201313.69; P &amp;lt; .001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PCP in the current era affects a broad range of patients who are immunocompromised, with high associated mortality and low rates of prophylaxis. Patients with solid tumors and those with cirrhosis are at particularly high risk of mortality. These findings highlight the need to reassess and redefine PCP prophylaxis guidelines in specific populations and our understanding of who is at risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf390","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T07:52:41Z","timestamp":1751097161000},"source":"Crossref","is-referenced-by-count":20,"title":["An Observational Analysis of a Large Cohort of\n                    <i>Pneumocystis jirovecii<\/i>\n                    Pneumonia"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8225-1361","authenticated-orcid":false,"given":"Aaron M","family":"Pulsipher","sequence":"first","affiliation":[{"name":"Department of Critical Care, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6391-0349","authenticated-orcid":false,"given":"Holenarasipur R","family":"Vikram","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Transplant Center, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7090-3825","authenticated-orcid":false,"given":"Michael B","family":"Gotway","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Radiology, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Cartin-Ceba","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle J","family":"Henry","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec M","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Transplant Center, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1608-041X","authenticated-orcid":false,"given":"Ryan R","family":"Gassner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9218-6743","authenticated-orcid":false,"given":"Kevin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7723-3320","authenticated-orcid":false,"given":"Dani B","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6066-8241","authenticated-orcid":false,"given":"Emily R","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H","family":"Limper","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8540-4789","authenticated-orcid":false,"given":"Ayan","family":"Sen","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8018-5145","authenticated-orcid":false,"given":"Augustine S","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Allergy and Pulmonary Medicine, Mayo Clinic , Jacksonville, Florida ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7085-5530","authenticated-orcid":false,"given":"Kealy","family":"Ham","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Mayo Clinic , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"2025072409170259500_ofaf390-B1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jinf.2005.06.014","article-title":"Pneumocystis pneumonia\u2014a retrospective study 1991\u20132001 in Gothenburg, Sweden","volume":"53","author":"Mikaelsson","year":"2006","journal-title":"J Infect"},{"key":"2025072409170259500_ofaf390-B2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.idc.2009.10.010","article-title":"Pneumocystis jirovecii pneumonia","volume":"24","author":"Catherinot","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"2025072409170259500_ofaf390-B3","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3201\/eid2009.131668","article-title":"Pneumocystis jirovecii pneumonia in patients with or without AIDS, France","volume":"20","author":"Roux","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2025072409170259500_ofaf390-B4","doi-asserted-by":"crossref","first-page":"1242.e11","DOI":"10.1016\/j.amjmed.2014.07.010","article-title":"Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients","volume":"127","author":"Fillatre","year":"2014","journal-title":"Am J Med"},{"key":"2025072409170259500_ofaf390-B5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2025072409170259500_ofaf390-B6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jinf.2023.02.014","article-title":"Rising incidence of Pneumocystis pneumonia: a population-level descriptive ecological study in England","volume":"86","author":"Pates","year":"2023","journal-title":"J Infect"},{"key":"2025072409170259500_ofaf390-B7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mib.2017.10.019","article-title":"New advances in understanding the host immune response to Pneumocystis","volume":"40","author":"Hoving","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"2025072409170259500_ofaf390-B8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.chest.2021.11.007","article-title":"Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients receiving rituximab","volume":"161","author":"Park","year":"2022","journal-title":"Chest"},{"key":"2025072409170259500_ofaf390-B9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"2025072409170259500_ofaf390-B10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","article-title":"Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital","volume":"267","author":"Sepkowitz","year":"1992","journal-title":"JAMA"},{"key":"2025072409170259500_ofaf390-B11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijid.2022.12.027","article-title":"Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series","volume":"128","author":"Franceschini","year":"2023","journal-title":"Int J Infect Dis"},{"key":"2025072409170259500_ofaf390-B12","doi-asserted-by":"crossref","first-page":"1474835","DOI":"10.3389\/fmed.2024.1474835","article-title":"Liver cirrhosis is a risk-factor for Pneumocystis jirovecii associated mortality","volume":"11","author":"Peschel","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"2025072409170259500_ofaf390-B13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/QCO.0000000000001002","article-title":"Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention","volume":"37","author":"Saadatzadeh","year":"2024","journal-title":"Curr Opin Infect Dis"},{"key":"2025072409170259500_ofaf390-B14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.2023.9844","article-title":"Prophylaxis against Pneumocystis jirovecii pneumonia in adults","volume":"330","author":"Zhou","year":"2023","journal-title":"JAMA"},{"key":"2025072409170259500_ofaf390-B15","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025072409170259500_ofaf390-B16","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1097\/TP.0000000000003576","article-title":"A comprehensive evaluation of risk factors for Pneumocystis jirovecii pneumonia in adult solid organ transplant recipients: a systematic review and meta-analysis","volume":"105","author":"Permpalung","year":"2021","journal-title":"Transplantation"},{"key":"2025072409170259500_ofaf390-B17","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1080\/10428194.2022.2056179","article-title":"Incidence of Pneumocystis jirovecii pneumonia (PJP) in patients receiving BTK inhibitors who did not receive PJP prophylaxis","volume":"63","author":"Davis","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"2025072409170259500_ofaf390-B18","doi-asserted-by":"crossref","first-page":"106926","DOI":"10.1016\/j.leukres.2022.106926","article-title":"Pneumocystis jirovecii pneumonia [PJP]: an unrecognized concern in AML patients on venetoclax","volume":"121","author":"Rainchwar","year":"2022","journal-title":"Leuk Res"},{"key":"2025072409170259500_ofaf390-B19","doi-asserted-by":"crossref","first-page":"bcr2014204950","DOI":"10.1136\/bcr-2014-204950","article-title":"Pneumocystis jiroveci pneumonitis complicating ruxolitinib therapy","volume":"2014","author":"Lee","year":"2014","journal-title":"BMJ Case Rep"},{"key":"2025072409170259500_ofaf390-B20","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/pathogens11101169","article-title":"Pneumocystis jirovecii pneumonia in patients with solid malignancies: a retrospective study in two hospitals","volume":"11","author":"Jeon","year":"2022","journal-title":"Pathogens"},{"key":"2025072409170259500_ofaf390-B21","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.chest.2024.01.015","article-title":"Characteristics and prognosis factors of Pneumocystis jirovecii pneumonia according to underlying disease: a retrospective multicenter study","volume":"165","author":"Lecuyer","year":"2024","journal-title":"Chest"},{"key":"2025072409170259500_ofaf390-B22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1399-3062.2012.00739.x","article-title":"Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)\u2013infected and HIV-uninfected persons","volume":"14","author":"McKinnell","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"2025072409170259500_ofaf390-B23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025072409170259500_ofaf390-B24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.diagmicrobio.2010.10.021","article-title":"Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity","volume":"69","author":"Wilson","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025072409170259500_ofaf390-B25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.diagmicrobio.2005.08.006","article-title":"A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid","volume":"54","author":"Arcenas","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025072409170259500_ofaf390-B26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2025072409170259500_ofaf390-B27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12890-019-0813-y","article-title":"Prognostic significance of crazy paving ground grass opacities in non-HIV Pneumocystis jirovecii pneumonia: an observational cohort study","volume":"19","author":"Kumagai","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2025072409170259500_ofaf390-B28","doi-asserted-by":"crossref","first-page":"ofad639","DOI":"10.1093\/ofid\/ofad639","article-title":"Epidemiology, risk factors, and prophylaxis use for Pneumocystis jirovecii pneumonia in the non-HIV population: a retrospective study in Quebec, Canada","volume":"11","author":"Quigley","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025072409170259500_ofaf390-B29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1705149","article-title":"Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study","volume":"36","author":"De Castro","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"2025072409170259500_ofaf390-B30","doi-asserted-by":"crossref","first-page":"e13587","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"key":"2025072409170259500_ofaf390-B31","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":"Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"2025072409170259500_ofaf390-B32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijid.2016.03.018","article-title":"Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients","volume":"46","author":"Bienvenu","year":"2016","journal-title":"Int J Infect Dis"},{"key":"2025072409170259500_ofaf390-B33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","article-title":"Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years","volume":"22","author":"Schmidt","year":"2018","journal-title":"Crit Care"},{"key":"2025072409170259500_ofaf390-B34","doi-asserted-by":"crossref","first-page":"e14417","DOI":"10.1111\/tid.14417","article-title":"Critical insights: severe outcomes of Pneumocystis pneumonia: a 10-year retrospective cohort study","volume":"27","author":"Winichakoon","year":"2025","journal-title":"Transpl Infect Dis"},{"key":"2025072409170259500_ofaf390-B35","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1128\/AAC.00669-11","article-title":"Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non\u2013HIV-infected patients","volume":"55","author":"Moon","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2025072409170259500_ofaf390-B36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.chest.2018.04.026","article-title":"Early corticosteroids for Pneumocystis pneumonia in adults without HIV are not associated with better outcome","volume":"154","author":"Wieruszewski","year":"2018","journal-title":"Chest"},{"issue":"7","key":"2025072409170259500_ofaf390-B37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/jof11070500","article-title":"Pneumocystis Pneumonia in Cirrhosis: An Underrecognized Fungal Infection in a Vulnerable Host","volume":"11","author":"Pulsipher","year":"2025","journal-title":"J Fungi"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf390\/63662060\/ofaf390.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/7\/ofaf390\/63662060\/ofaf390.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/7\/ofaf390\/63662060\/ofaf390.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T13:17:12Z","timestamp":1753363032000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf390\/8185524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf390","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,6,30]]},"article-number":"ofaf390"}}